US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Armata Pharmaceuticals, Inc.

8.37

-0.9800-10.48%

Post-market: 8.370.00000.00%16:40 EDT

Volume:27.11K

Turnover:233.78K

Market Cap:306.62M

PE:-1.74

High:9.09

Open:9.09

Low:8.25

Close:9.35

52wk High:16.34

52wk Low:0.8981

Shares:36.63M

Float Shares:10.87M

Volume Ratio:0.71

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8000

EPS(LYR):-0.8886

ROE:-3439.35%

ROA:-22.20%

PB:-3.21

PE(LYR):-9.42

Loading ...

Overview Company News Filings

Armata Pharmaceuticals FY2025 net loss more than doubled to $174 million; revenue slips 5.22% to $4.9 million

Armata Pharmaceuticals Inc - Q4 2025 Net Loss $-3.42 per Share

THOMSON REUTERS

Press Release: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results

Armata Pharmaceuticals delays Q4 and full-year 2025 results announcement

Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update

THOMSON REUTERS

Armata price target raised to $15 from $9 at H.C. Wainwright

Armata Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $15 From $9

THOMSON REUTERS

FDA Grants QIDP Designation to Armata Pharmaceuticals’ AP-SA02

Armata: Plans to Advance AP-Sa02 Into Phase 3 Superiority Study in Complicated S. Aureus Bacteremia, Anticipated to Initiate in Second Half of 2026

THOMSON REUTERS

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (Qidp) Designation for AP-Sa02

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Akamai Technologies, Albemarle, Nordson

Armata Pharmaceuticals Inc - Amends Four Existing Credit Agreements - SEC Filing

THOMSON REUTERS

Armata Pharmaceuticals Extends Loan Maturities With Innoviva to 2027

Rpt-Armata Pharmaceuticals Inc: FDA Agreed That Data From Phase 2a Disarm Study Support Advancement of AP-Sa02 to a Phase 3 Study

THOMSON REUTERS

Armata Advances Phage Therapy Candidate AP-SA02 to Phase 3 After Positive FDA Review

Armata Pharmaceuticals Inc: Phase 3 Study Is Anticipated to Initiate in Second Half of 2026.

THOMSON REUTERS

Armata Pharmaceuticals Announces End-of-Phase 2 Meeting With FDA and Plans to Advance AP-Sa02 to a Phase 3 Superiority Study in Complicated Bacteremiastaphylococcusaureus

THOMSON REUTERS

Armata Pharmaceuticals Initiated at Buy by Jones Trading

Armata Pharmaceuticals Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $15

THOMSON REUTERS

Armata Pharmaceuticals Reports Positive Phase 2a Results for AP-SA02 in Staph Aureus Bacteremia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARMP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARMP\",,,,,undefined,":{"symbol":"ARMP","market":"US","secType":"STK","nameCN":"Armata Pharmaceuticals, Inc.","latestPrice":8.37,"timestamp":1774641600000,"preClose":9.35,"halted":0,"volume":27107,"hourTrading":{"tag":"盘后","latestPrice":8.37,"preClose":8.37,"latestTime":"16:40 EDT","volume":44,"amount":357.08,"timestamp":1774644025049,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.10481283422459899,"floatShares":10874618,"shares":36632775,"eps":-4.8,"marketStatus":"Market Closed","change":-0.98,"latestTime":"03-27 16:00:00 EDT","open":9.09,"high":9.09,"low":8.25,"amount":233775.3459,"amplitude":0.08984,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-4.8,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":9.35,"preHourTrading":{"tag":"盘前","latestPrice":8.56,"preClose":9.35,"latestTime":"07:16 EDT","volume":79,"amount":676.24,"timestamp":1774610201147,"change":-0.79,"changeRate":-0.084492,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":8.37,"preClose":8.37,"latestTime":"16:40 EDT","volume":44,"amount":357.08,"timestamp":1774644025049,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.707758,"impliedVol":1.7877,"impliedVolPercentile":0.7052},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARMP\",,,,,undefined,":{"symbol":"ARMP","floatShares":10874618,"roa":"-22.20%","roe":"-3439.35%","lyrEps":-0.888605,"volumeRatio":0.707758,"shares":36632775,"dividePrice":0,"high":9.09,"amplitude":0.08984,"preClose":9.35,"low":8.25,"week52Low":0.8981,"pbRate":"-3.21","psRate":"60.67","week52High":16.34,"institutionHeld":0.05,"latestPrice":8.37,"eps":-4.8,"divideRate":0,"volume":27107,"delay":0,"ttmEps":-4.8,"open":9.09,"prevYearClose":6.28,"prevWeekClose":8.39,"prevMonthClose":10.76,"prevQuarterClose":6.28,"fiveDayClose":8.39,"twentyDayClose":10.76,"sixtyDayClose":6.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-25","symbol":"ARMP","fiscalQuarterEnding":"2025/12","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2025-11-12","symbol":"ARMP","fiscalQuarterEnding":"2025/09","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2025-08-22","symbol":"ARMP","fiscalQuarterEnding":"2025/06","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755835200000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-05-14","symbol":"ARMP","fiscalQuarterEnding":"2025/03","expectedEps":-0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2025-03-20","symbol":"ARMP","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARMP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1767672000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARMP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARMP","date":"2026-03-26","current":-1.74375,"percent":0.113377,"low":-230.244901,"twenty":-5.637629,"median":-3.579718,"eighty":-1.74079,"high":-0.932507,"avg":-12.296266,"sd":38.841543,"marketCap":313463452},"quantilePoints":[{"date":"2021-04-01","current":-5.329683,"twenty":-3.524633,"median":-2.953992,"eighty":-2.404258,"marketCap":118217695},{"date":"2021-04-09","current":-5.194754,"twenty":-3.537637,"median":-2.957652,"eighty":-2.404258,"marketCap":115224842},{"date":"2021-04-16","current":-4.610063,"twenty":-3.553236,"median":-2.967224,"eighty":-2.406241,"marketCap":102255812},{"date":"2021-04-23","current":-4.655039,"twenty":-3.558039,"median":-2.975958,"eighty":-2.429655,"marketCap":103253429},{"date":"2021-04-30","current":-4.610063,"twenty":-3.582418,"median":-3.002452,"eighty":-2.461392,"marketCap":102255812},{"date":"2021-05-07","current":-4.688772,"twenty":-3.61777,"median":-3.017481,"eighty":-2.46549,"marketCap":104001643},{"date":"2021-05-14","current":-4.403592,"twenty":-3.627198,"median":-3.02135,"eighty":-2.470794,"marketCap":99512363},{"date":"2021-05-21","current":-4.817463,"twenty":-3.635421,"median":-3.037227,"eighty":-2.47323,"marketCap":108865029},{"date":"2021-05-28","current":-4.414628,"twenty":-3.701729,"median":-3.040512,"eighty":-2.475311,"marketCap":99761768},{"date":"2021-06-04","current":-4.458774,"twenty":-3.755513,"median":-3.049675,"eighty":-2.47896,"marketCap":100759385},{"date":"2021-06-11","current":-5.065786,"twenty":-3.763895,"median":-3.053472,"eighty":-2.48344,"marketCap":114476628},{"date":"2021-06-18","current":-4.613286,"twenty":-3.873799,"median":-3.063213,"eighty":-2.490821,"marketCap":104251047},{"date":"2021-06-25","current":-4.414628,"twenty":-3.920176,"median":-3.063486,"eighty":-2.493615,"marketCap":99761768},{"date":"2021-07-02","current":-4.502921,"twenty":-4.23059,"median":-3.081538,"eighty":-2.503799,"marketCap":101757003},{"date":"2021-07-09","current":-4.425665,"twenty":-4.392555,"median":-3.087983,"eighty":-2.506436,"marketCap":100011172},{"date":"2021-07-16","current":-4.138714,"twenty":-4.381518,"median":-3.105016,"eighty":-2.507328,"marketCap":93526657},{"date":"2021-07-23","current":-4.414628,"twenty":-4.392555,"median":-3.119951,"eighty":-2.509351,"marketCap":99761768},{"date":"2021-07-30","current":-4.227006,"twenty":-4.381518,"median":-3.123498,"eighty":-2.509351,"marketCap":95521892},{"date":"2021-08-06","current":-4.21597,"twenty":-4.381518,"median":-3.14349,"eighty":-2.510842,"marketCap":95272488},{"date":"2021-08-13","current":-3.94685,"twenty":-4.381518,"median":-3.158657,"eighty":-2.516115,"marketCap":95048030},{"date":"2021-08-20","current":-3.929867,"twenty":-4.337372,"median":-3.164073,"eighty":-2.525399,"marketCap":94639049},{"date":"2021-08-27","current":-3.924689,"twenty":-4.315299,"median":-3.166329,"eighty":-2.529787,"marketCap":94514360},{"date":"2021-09-03","current":-3.686515,"twenty":-4.293226,"median":-3.16948,"eighty":-2.531091,"marketCap":88778660},{"date":"2021-09-10","current":-4.059309,"twenty":-4.293226,"median":-3.179187,"eighty":-2.533943,"marketCap":97756277},{"date":"2021-09-17","current":-3.986821,"twenty":-4.288812,"median":-3.196944,"eighty":-2.544226,"marketCap":96010630},{"date":"2021-09-24","current":-3.764181,"twenty":-4.284176,"median":-3.198232,"eighty":-2.546619,"marketCap":90648997},{"date":"2021-10-01","current":-3.748648,"twenty":-4.28241,"median":-3.203172,"eighty":-2.546619,"marketCap":90274930},{"date":"2021-10-08","current":-3.572606,"twenty":-4.27336,"median":-3.211378,"eighty":-2.546619,"marketCap":86035499},{"date":"2021-10-15","current":-3.572606,"twenty":-4.271153,"median":-3.221741,"eighty":-2.54798,"marketCap":86035499},{"date":"2021-10-22","current":-3.127325,"twenty":-4.269475,"median":-3.227437,"eighty":-2.55168,"marketCap":75312234},{"date":"2021-10-29","current":-3.313722,"twenty":-4.253075,"median":-3.221138,"eighty":-2.557787,"marketCap":79801043},{"date":"2021-11-05","current":-4.089236,"twenty":-4.235836,"median":-3.233762,"eighty":-2.561851,"marketCap":98476981},{"date":"2021-11-12","current":-3.846318,"twenty":-4.22811,"median":-3.244803,"eighty":-2.565136,"marketCap":91280827},{"date":"2021-11-19","current":-4.474056,"twenty":-4.253075,"median":-3.260497,"eighty":-2.570328,"marketCap":106178292},{"date":"2021-11-26","current":-5.957799,"twenty":-4.274703,"median":-3.266128,"eighty":-2.578918,"marketCap":141390480},{"date":"2021-12-03","current":-5.136033,"twenty":-4.289915,"median":-3.269278,"eighty":-2.58575,"marketCap":121888345},{"date":"2021-12-10","current":-5.66105,"twenty":-4.35503,"median":-3.277105,"eighty":-2.58705,"marketCap":134348043},{"date":"2021-12-17","current":-5.752357,"twenty":-4.39697,"median":-3.286958,"eighty":-2.589336,"marketCap":136514946},{"date":"2021-12-23","current":-6.459989,"twenty":-4.414628,"median":-3.30478,"eighty":-2.593024,"marketCap":153308452},{"date":"2021-12-31","current":-6.254547,"twenty":-4.432287,"median":-3.312774,"eighty":-2.597656,"marketCap":148432918},{"date":"2022-01-07","current":-6.779564,"twenty":-4.451049,"median":-3.322326,"eighty":-2.602086,"marketCap":160892616},{"date":"2022-01-14","current":-6.574123,"twenty":-4.466877,"median":-3.32717,"eighty":-2.606756,"marketCap":156017082},{"date":"2022-01-21","current":-6.254547,"twenty":-4.498506,"median":-3.340604,"eighty":-2.608374,"marketCap":148432918},{"date":"2022-01-28","current":-5.763771,"twenty":-4.568329,"median":-3.354877,"eighty":-2.609192,"marketCap":136785809},{"date":"2022-02-04","current":-5.843665,"twenty":-4.59323,"median":-3.363741,"eighty":-2.612942,"marketCap":138681850},{"date":"2022-02-11","current":-6.797456,"twenty":-4.610063,"median":-3.376429,"eighty":-2.618843,"marketCap":161317227},{"date":"2022-02-18","current":-6.486715,"twenty":-4.612641,"median":-3.38937,"eighty":-2.626149,"marketCap":153942725},{"date":"2022-02-25","current":-6.603243,"twenty":-4.624323,"median":-3.398819,"eighty":-2.627366,"marketCap":156708164},{"date":"2022-03-04","current":-6.486715,"twenty":-4.643795,"median":-3.406766,"eighty":-2.62753,"marketCap":153942725},{"date":"2022-03-11","current":-5.127224,"twenty":-4.668469,"median":-3.413667,"eighty":-2.634322,"marketCap":121679280},{"date":"2022-03-18","current":-7.046463,"twenty":-4.688772,"median":-3.415178,"eighty":-2.634598,"marketCap":163160853},{"date":"2022-03-25","current":-6.887221,"twenty":-4.722504,"median":-3.420212,"eighty":-2.642738,"marketCap":159473602},{"date":"2022-04-01","current":-7.953907,"twenty":-4.817463,"median":-3.421487,"eighty":-2.645999,"marketCap":184172724},{"date":"2022-04-08","current":-7.797948,"twenty":-4.879921,"median":-3.431056,"eighty":-2.645999,"marketCap":180561495},{"date":"2022-04-14","current":-7.844736,"twenty":-4.929019,"median":-3.438408,"eighty":-2.653506,"marketCap":181644863},{"date":"2022-04-22","current":-6.69064,"twenty":-5.058069,"median":-3.445124,"eighty":-2.659761,"marketCap":154921762},{"date":"2022-04-29","current":-7.197506,"twenty":-5.173298,"median":-3.453108,"eighty":-2.666362,"marketCap":166658259},{"date":"2022-05-06","current":-6.526883,"twenty":-5.272128,"median":-3.474107,"eighty":-2.668669,"marketCap":151129971},{"date":"2022-05-13","current":-5.382555,"twenty":-5.361533,"median":-3.486678,"eighty":-2.670455,"marketCap":142282458},{"date":"2022-05-20","current":-5.806055,"twenty":-5.385473,"median":-3.492947,"eighty":-2.680758,"marketCap":153477270},{"date":"2022-05-27","current":-5.696726,"twenty":-5.439211,"median":-3.50476,"eighty":-2.683261,"marketCap":150587261},{"date":"2022-06-03","current":-6.489077,"twenty":-5.480051,"median":-3.510769,"eighty":-2.685119,"marketCap":171532251},{"date":"2022-06-10","current":-6.236344,"twenty":-5.524357,"median":-3.519725,"eighty":-2.690054,"marketCap":164851521},{"date":"2022-06-17","current":-4.945359,"twenty":-5.517241,"median":-3.524616,"eighty":-2.692521,"marketCap":130725631},{"date":"2022-06-24","current":-4.576507,"twenty":-5.506943,"median":-3.528816,"eighty":-2.697361,"marketCap":120975377},{"date":"2022-07-01","current":-5.000004,"twenty":-5.493544,"median":-3.537637,"eighty":-2.709722,"marketCap":132170113},{"date":"2022-07-08","current":-4.781425,"twenty":-5.484246,"median":-3.546594,"eighty":-2.718006,"marketCap":126392185},{"date":"2022-07-15","current":-5.669404,"twenty":-5.495944,"median":-3.55555,"eighty":-2.720535,"marketCap":149865019},{"date":"2022-07-22","current":-5.751371,"twenty":-5.50981,"median":-3.557831,"eighty":-2.72236,"marketCap":152031743},{"date":"2022-07-29","current":-5.62842,"twenty":-5.521806,"median":-3.569598,"eighty":-2.72966,"marketCap":148781658},{"date":"2022-08-05","current":-5.614759,"twenty":-5.538956,"median":-3.572606,"eighty":-2.729904,"marketCap":148420537},{"date":"2022-08-12","current":-5.177116,"twenty":-5.585722,"median":-3.582418,"eighty":-2.730879,"marketCap":152491966},{"date":"2022-08-19","current":-4.864159,"twenty":-5.554973,"median":-3.582961,"eighty":-2.73263,"marketCap":143273790},{"date":"2022-08-26","current":-5.054436,"twenty":-5.538956,"median":-3.590365,"eighty":-2.739632,"marketCap":148878412},{"date":"2022-09-02","current":-4.944024,"twenty":-5.52783,"median":-3.594795,"eighty":-2.741382,"marketCap":145626214},{"date":"2022-09-09","current":-4.441034,"twenty":-5.524759,"median":-3.617061,"eighty":-2.748384,"marketCap":130810643},{"date":"2022-09-16","current":-5.164848,"twenty":-5.524089,"median":-3.625383,"eighty":-2.749506,"marketCap":152130610},{"date":"2022-09-23","current":-6.03588,"twenty":-5.541545,"median":-3.627198,"eighty":-2.757137,"marketCap":177786842},{"date":"2022-09-30","current":-5.177116,"twenty":-5.541545,"median":-3.634103,"eighty":-2.757137,"marketCap":152491966},{"date":"2022-10-07","current":-5.042168,"twenty":-5.528598,"median":-3.645094,"eighty":-2.757225,"marketCap":148517057},{"date":"2022-10-14","current":-4.281549,"twenty":-5.524759,"median":-3.668691,"eighty":-2.760802,"marketCap":126113024},{"date":"2022-10-21","current":-4.294907,"twenty":-5.524089,"median":-3.689131,"eighty":-2.764665,"marketCap":126506471},{"date":"2022-10-28","current":-3.810196,"twenty":-5.512676,"median":-3.723291,"eighty":-2.765803,"marketCap":112229312},{"date":"2022-11-04","current":-3.552501,"twenty":-5.505469,"median":-3.689131,"eighty":-2.76589,"marketCap":104638923},{"date":"2022-11-11","current":-3.177192,"twenty":-5.498344,"median":-3.683931,"eighty":-2.76589,"marketCap":103735306},{"date":"2022-11-18","current":-2.82294,"twenty":-5.486343,"median":-3.679266,"eighty":-2.771347,"marketCap":92169000},{"date":"2022-11-25","current":-2.225141,"twenty":-5.479786,"median":-3.651186,"eighty":-2.765575,"marketCap":72650859},{"date":"2022-12-02","current":-2.49083,"twenty":-5.476314,"median":-3.635237,"eighty":-2.757137,"marketCap":81325588},{"date":"2022-12-09","current":-2.070156,"twenty":-5.46676,"median":-3.631076,"eighty":-2.739632,"marketCap":67590600},{"date":"2022-12-16","current":-1.749116,"twenty":-5.455591,"median":-3.627198,"eighty":-2.72966,"marketCap":57108635},{"date":"2022-12-23","current":-1.428076,"twenty":-5.446029,"median":-3.624877,"eighty":-2.714823,"marketCap":46626670},{"date":"2022-12-30","current":-1.372724,"twenty":-5.440457,"median":-3.617061,"eighty":-2.690054,"marketCap":44819435},{"date":"2023-01-06","current":-1.54985,"twenty":-5.431327,"median":-3.594795,"eighty":-2.675801,"marketCap":50602588},{"date":"2023-01-13","current":-2.435478,"twenty":-5.417741,"median":-3.590365,"eighty":-2.658473,"marketCap":79518353},{"date":"2023-01-20","current":-2.944714,"twenty":-5.409268,"median":-3.583179,"eighty":-2.657679,"marketCap":96144917},{"date":"2023-01-27","current":-3.642146,"twenty":-5.396954,"median":-3.583179,"eighty":-2.662233,"marketCap":118916082},{"date":"2023-02-03","current":-3.166121,"twenty":-5.394079,"median":-3.58307,"eighty":-2.667971,"marketCap":103373859},{"date":"2023-02-10","current":-3.027742,"twenty":-5.385049,"median":-3.582418,"eighty":-2.66929,"marketCap":98855770},{"date":"2023-02-17","current":-3.077558,"twenty":-5.382548,"median":-3.580179,"eighty":-2.673323,"marketCap":100482282},{"date":"2023-02-24","current":-2.81187,"twenty":-5.382518,"median":-3.572606,"eighty":-2.670844,"marketCap":91807553},{"date":"2023-03-03","current":-3.055418,"twenty":-5.374659,"median":-3.570908,"eighty":-2.683237,"marketCap":99759388},{"date":"2023-03-10","current":-2.18086,"twenty":-5.368857,"median":-3.558005,"eighty":-2.668901,"marketCap":71205070},{"date":"2023-03-17","current":-1.860252,"twenty":-5.364302,"median":-3.55555,"eighty":-2.656885,"marketCap":68674941},{"date":"2023-03-24","current":-2.694263,"twenty":-5.363415,"median":-3.553043,"eighty":-2.656885,"marketCap":99464089},{"date":"2023-03-31","current":-3.081793,"twenty":-5.361062,"median":-3.546594,"eighty":-2.660856,"marketCap":113770568},{"date":"2023-04-06","current":-2.786532,"twenty":-5.356369,"median":-3.537637,"eighty":-2.666362,"marketCap":102870394},{"date":"2023-04-14","current":-2.768078,"twenty":-5.344267,"median":-3.528816,"eighty":-2.666362,"marketCap":102189133},{"date":"2023-04-21","current":-2.987679,"twenty":-5.332053,"median":-3.524531,"eighty":-2.668669,"marketCap":110296138},{"date":"2023-04-28","current":-2.860347,"twenty":-5.325403,"median":-3.515675,"eighty":-2.670455,"marketCap":105595437},{"date":"2023-05-05","current":-2.841893,"twenty":-5.316236,"median":-3.510769,"eighty":-2.680758,"marketCap":104914177},{"date":"2023-05-11","current":-2.49127,"twenty":-5.314212,"median":-3.509238,"eighty":-2.670844,"marketCap":91970220},{"date":"2023-05-19","current":-1.102154,"twenty":-5.314212,"median":-3.499404,"eighty":-2.656885,"marketCap":46988117},{"date":"2023-05-26","current":-1.186935,"twenty":-5.284707,"median":-3.490884,"eighty":-2.645999,"marketCap":50602588},{"date":"2023-06-02","current":-1.271716,"twenty":-5.275525,"median":-3.48094,"eighty":-2.634543,"marketCap":54217059},{"date":"2023-06-09","current":-1.322584,"twenty":-5.270681,"median":-3.470048,"eighty":-2.626758,"marketCap":56385741},{"date":"2023-06-16","current":-1.220847,"twenty":-5.263333,"median":-3.448825,"eighty":-2.608444,"marketCap":52048376},{"date":"2023-06-23","current":-1.237803,"twenty":-5.25603,"median":-3.445124,"eighty":-2.600419,"marketCap":52771270},{"date":"2023-06-30","current":-1.051115,"twenty":-5.250613,"median":-3.439121,"eighty":-2.587838,"marketCap":44812206},{"date":"2023-07-07","current":-0.974982,"twenty":-5.250167,"median":-3.431946,"eighty":-2.571464,"marketCap":41566411},{"date":"2023-07-14","current":-1.000416,"twenty":-5.235144,"median":-3.4225,"eighty":-2.55252,"marketCap":42650753},{"date":"2023-07-21","current":-1.017373,"twenty":-5.213921,"median":-3.421209,"eighty":-2.546619,"marketCap":43373647},{"date":"2023-07-28","current":-2.111048,"twenty":-5.194754,"median":-3.416227,"eighty":-2.531091,"marketCap":90000317},{"date":"2023-08-04","current":-3.128421,"twenty":-5.191297,"median":-3.415081,"eighty":-2.525399,"marketCap":133373965},{"date":"2023-08-11","current":-3.425155,"twenty":-5.177424,"median":-3.412253,"eighty":-2.529787,"marketCap":146024612},{"date":"2023-08-18","current":-3.850712,"twenty":-5.177116,"median":-3.415178,"eighty":-2.531091,"marketCap":142341585},{"date":"2023-08-25","current":-2.844054,"twenty":-5.177116,"median":-3.415129,"eighty":-2.534656,"marketCap":105130460},{"date":"2023-09-01","current":-3.38159,"twenty":-5.172266,"median":-3.412253,"eighty":-2.546181,"marketCap":125000478},{"date":"2023-09-08","current":-2.990655,"twenty":-5.166332,"median":-3.406766,"eighty":-2.546531,"marketCap":110549556},{"date":"2023-09-15","current":-2.863601,"twenty":-5.16423,"median":-3.398819,"eighty":-2.546619,"marketCap":105853006},{"date":"2023-09-22","current":-2.589946,"twenty":-5.163966,"median":-3.388956,"eighty":-2.546619,"marketCap":95737360},{"date":"2023-09-29","current":-2.756094,"twenty":-5.15301,"median":-3.380585,"eighty":-2.546619,"marketCap":101879002},{"date":"2023-10-06","current":-2.541079,"twenty":-5.138882,"median":-3.37292,"eighty":-2.546619,"marketCap":93930995},{"date":"2023-10-13","current":-2.120824,"twenty":-5.129642,"median":-3.359509,"eighty":-2.546531,"marketCap":78396254},{"date":"2023-10-20","current":-1.93513,"twenty":-5.127388,"median":-3.354526,"eighty":-2.53083,"marketCap":71532065},{"date":"2023-10-27","current":-2.032863,"twenty":-5.122481,"median":-3.349561,"eighty":-2.526277,"marketCap":75144796},{"date":"2023-11-03","current":-2.238202,"twenty":-5.095964,"median":-3.331648,"eighty":-2.509649,"marketCap":82735143},{"date":"2023-11-10","current":-2.326065,"twenty":-5.063857,"median":-3.322692,"eighty":-2.503799,"marketCap":85982988},{"date":"2023-11-17","current":-1.220189,"twenty":-5.055842,"median":-3.321106,"eighty":-2.491241,"marketCap":72615885},{"date":"2023-11-24","current":-1.232987,"twenty":-5.054649,"median":-3.313684,"eighty":-2.490718,"marketCap":73377545},{"date":"2023-12-01","current":-1.330169,"twenty":-5.054649,"median":-3.311804,"eighty":-2.473168,"marketCap":79160997},{"date":"2023-12-08","current":-1.694598,"twenty":-5.054436,"median":-3.297395,"eighty":-2.435478,"marketCap":100848941},{"date":"2023-12-15","current":-1.652082,"twenty":-5.054436,"median":-3.286958,"eighty":-2.404258,"marketCap":98318681},{"date":"2023-12-22","current":-1.451645,"twenty":-5.049539,"median":-3.277105,"eighty":-2.391325,"marketCap":86390311},{"date":"2023-12-29","current":-1.943625,"twenty":-5.049539,"median":-3.273518,"eighty":-2.373339,"marketCap":115669036},{"date":"2024-01-05","current":-1.943625,"twenty":-5.048065,"median":-3.270913,"eighty":-2.35083,"marketCap":115669036},{"date":"2024-01-12","current":-2.210874,"twenty":-5.036541,"median":-3.268956,"eighty":-2.325032,"marketCap":131573529},{"date":"2024-01-19","current":-2.338424,"twenty":-5.014034,"median":-3.262115,"eighty":-2.313704,"marketCap":139164309},{"date":"2024-01-26","current":-2.368793,"twenty":-5.000004,"median":-3.247199,"eighty":-2.323001,"marketCap":140971638},{"date":"2024-02-02","current":-2.350572,"twenty":-5.000004,"median":-3.238636,"eighty":-2.323001,"marketCap":139887241},{"date":"2024-02-09","current":-2.405236,"twenty":-4.993096,"median":-3.231278,"eighty":-2.323001,"marketCap":143140433},{"date":"2024-02-16","current":-1.955773,"twenty":-4.993096,"median":-3.221138,"eighty":-2.301981,"marketCap":116391968},{"date":"2024-02-23","current":-1.761411,"twenty":-4.987694,"median":-3.210403,"eighty":-2.300711,"marketCap":104825064},{"date":"2024-03-01","current":-2.393089,"twenty":-4.981931,"median":-3.206466,"eighty":-2.295826,"marketCap":142417501},{"date":"2024-03-08","current":-2.156209,"twenty":-4.971014,"median":-3.203172,"eighty":-2.291217,"marketCap":128320337},{"date":"2024-03-15","current":-2.052954,"twenty":-4.949999,"median":-3.198232,"eighty":-2.270397,"marketCap":122175420},{"date":"2024-03-22","current":-1.931796,"twenty":-4.944291,"median":-3.196944,"eighty":-2.246235,"marketCap":133380858},{"date":"2024-03-28","current":-2.146557,"twenty":-4.944024,"median":-3.179396,"eighty":-2.237373,"marketCap":148209009},{"date":"2024-04-05","current":-1.947608,"twenty":-4.944024,"median":-3.173816,"eighty":-2.222508,"marketCap":134472565},{"date":"2024-04-12","current":-1.732952,"twenty":-4.936663,"median":-3.16852,"eighty":-2.207447,"marketCap":119651664},{"date":"2024-04-19","current":-1.335054,"twenty":-4.917361,"median":-3.166078,"eighty":-2.194783,"marketCap":92178774},{"date":"2024-04-26","current":-1.325001,"twenty":-4.907437,"median":-3.162112,"eighty":-2.18408,"marketCap":91484722},{"date":"2024-05-03","current":-1.30386,"twenty":-4.907219,"median":-3.153872,"eighty":-2.174144,"marketCap":90024996},{"date":"2024-05-10","current":-1.481151,"twenty":-4.907219,"median":-3.143981,"eighty":-2.158719,"marketCap":117864051},{"date":"2024-05-17","current":-1.204003,"twenty":-4.907219,"median":-3.143981,"eighty":-2.15378,"marketCap":95809735},{"date":"2024-05-24","current":-1.181286,"twenty":-4.907219,"median":-3.143981,"eighty":-2.15378,"marketCap":94002004},{"date":"2024-05-31","current":-1.22672,"twenty":-4.907219,"median":-3.143981,"eighty":-2.146826,"marketCap":97617465},{"date":"2024-06-07","current":-1.167656,"twenty":-4.907219,"median":-3.143981,"eighty":-2.146826,"marketCap":92917365},{"date":"2024-06-14","current":-1.303958,"twenty":-4.907219,"median":-3.145723,"eighty":-2.14815,"marketCap":103763750},{"date":"2024-06-21","current":-1.284512,"twenty":-4.907219,"median":-3.147465,"eighty":-2.151351,"marketCap":102216333},{"date":"2024-06-28","current":-1.258524,"twenty":-4.907219,"median":-3.153872,"eighty":-2.157715,"marketCap":100148289},{"date":"2024-07-05","current":-1.149482,"twenty":-4.907219,"median":-3.153872,"eighty":-2.146718,"marketCap":91471181},{"date":"2024-07-12","current":-1.363022,"twenty":-4.907219,"median":-3.153872,"eighty":-2.144062,"marketCap":108463851},{"date":"2024-07-15","current":-1.431173,"twenty":-4.907219,"median":-3.153872,"eighty":-2.144062,"marketCap":113887043},{"date":"2024-08-02","current":-1.24035,"twenty":-4.931755,"median":-3.162112,"eighty":-2.150136,"marketCap":98702104},{"date":"2024-08-09","current":-1.163112,"twenty":-4.931755,"median":-3.143981,"eighty":-2.125508,"marketCap":92555819},{"date":"2024-08-16","current":-1.315831,"twenty":-4.931755,"median":-3.13291,"eighty":-2.111048,"marketCap":88217265},{"date":"2024-08-23","current":-1.192736,"twenty":-4.931755,"median":-3.127325,"eighty":-2.089397,"marketCap":79964578},{"date":"2024-08-30","current":-1.333058,"twenty":-4.931755,"median":-3.106614,"eighty":-2.052954,"marketCap":89372175},{"date":"2024-09-06","current":-1.295279,"twenty":-4.931755,"median":-3.082084,"eighty":-2.041847,"marketCap":86839360},{"date":"2024-09-13","current":-1.187339,"twenty":-4.931755,"median":-3.077558,"eighty":-2.018661,"marketCap":79602747},{"date":"2024-09-20","current":-1.20353,"twenty":-4.931755,"median":-3.063486,"eighty":-2.003133,"marketCap":80688239},{"date":"2024-09-27","current":-1.235912,"twenty":-4.931755,"median":-3.055418,"eighty":-1.96276,"marketCap":82859223},{"date":"2024-10-04","current":-1.241309,"twenty":-4.931755,"median":-3.053472,"eighty":-1.943625,"marketCap":83221054},{"date":"2024-10-11","current":-1.268294,"twenty":-4.931755,"median":-3.04598,"eighty":-1.925492,"marketCap":85030207},{"date":"2024-10-18","current":-1.27396,"twenty":-4.931755,"median":-3.037227,"eighty":-1.904643,"marketCap":85410129},{"date":"2024-10-25","current":-1.289828,"twenty":-4.931755,"median":-3.027742,"eighty":-1.890017,"marketCap":86473911},{"date":"2024-10-31","current":-1.241309,"twenty":-4.931755,"median":-3.022207,"eighty":-1.868013,"marketCap":83221054},{"date":"2024-11-08","current":-1.208927,"twenty":-4.934209,"median":-3.009966,"eighty":-1.839507,"marketCap":81050070},{"date":"2024-11-15","current":-2.344381,"twenty":-4.934209,"median":-2.995939,"eighty":-1.81136,"marketCap":96970619},{"date":"2024-11-22","current":-1.837015,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":75984440},{"date":"2024-11-29","current":-2.011969,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":83221054},{"date":"2024-12-06","current":-1.898249,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":78517255},{"date":"2024-12-13","current":-1.837015,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":75984440},{"date":"2024-12-20","current":-1.732042,"twenty":-4.934209,"median":-2.995939,"eighty":-1.791517,"marketCap":71642472},{"date":"2024-12-27","current":-1.767033,"twenty":-4.934209,"median":-2.995939,"eighty":-1.778768,"marketCap":73089795},{"date":"2025-01-03","current":-1.704925,"twenty":-4.934209,"median":-2.995939,"eighty":-1.762398,"marketCap":70520797},{"date":"2025-01-10","current":-1.810772,"twenty":-4.936663,"median":-2.995939,"eighty":-1.765278,"marketCap":74898948},{"date":"2025-01-17","current":-1.784529,"twenty":-4.936663,"median":-2.995939,"eighty":-1.762151,"marketCap":73813456},{"date":"2025-01-24","current":-1.906996,"twenty":-4.936663,"median":-2.995939,"eighty":-1.765283,"marketCap":78879086},{"date":"2025-01-31","current":-1.793276,"twenty":-4.936663,"median":-2.995939,"eighty":-1.767033,"marketCap":74175287},{"date":"2025-02-07","current":-1.784529,"twenty":-4.936663,"median":-2.995939,"eighty":-1.767033,"marketCap":73813456},{"date":"2025-02-14","current":-1.74079,"twenty":-4.936663,"median":-2.995939,"eighty":-1.762151,"marketCap":72004303},{"date":"2025-02-21","current":-1.758286,"twenty":-4.936663,"median":-2.995939,"eighty":-1.75127,"marketCap":72727964},{"date":"2025-02-28","current":-1.819519,"twenty":-4.936663,"median":-2.995939,"eighty":-1.75127,"marketCap":75260779},{"date":"2025-03-07","current":-1.837015,"twenty":-4.939116,"median":-2.995939,"eighty":-1.749285,"marketCap":75984440},{"date":"2025-03-14","current":-1.723295,"twenty":-4.939116,"median":-2.995939,"eighty":-1.74079,"marketCap":71280641},{"date":"2025-03-21","current":-1.758286,"twenty":-4.939116,"median":-2.995939,"eighty":-1.74079,"marketCap":72727964},{"date":"2025-03-28","current":-3.156359,"twenty":-4.939116,"median":-3.018954,"eighty":-1.74412,"marketCap":59705678},{"date":"2025-04-04","current":-2.524934,"twenty":-4.939116,"median":-3.018954,"eighty":-1.74412,"marketCap":47761648},{"date":"2025-04-11","current":-1.729197,"twenty":-4.936663,"median":-2.995939,"eighty":-1.74079,"marketCap":32709492},{"date":"2025-04-17","current":-2.257138,"twenty":-4.936663,"median":-2.990655,"eighty":-1.74079,"marketCap":42696019},{"date":"2025-04-25","current":-2.585953,"twenty":-4.939116,"median":-2.985569,"eighty":-1.74079,"marketCap":48915888},{"date":"2025-05-02","current":-2.572755,"twenty":-4.939116,"median":-2.971089,"eighty":-1.74079,"marketCap":48666225},{"date":"2025-05-09","current":-2.601447,"twenty":-4.939116,"median":-2.969123,"eighty":-1.74079,"marketCap":49208971},{"date":"2025-05-16","current":-118.911486,"twenty":-4.944024,"median":-2.969123,"eighty":-1.74079,"marketCap":50656293},{"date":"2025-05-23","current":-158.831772,"twenty":-4.984137,"median":-2.971089,"eighty":-1.74079,"marketCap":67662335},{"date":"2025-05-30","current":-184.365843,"twenty":-5.000004,"median":-2.971089,"eighty":-1.74079,"marketCap":78539849},{"date":"2025-06-06","current":-166.523986,"twenty":-5.052477,"median":-2.971089,"eighty":-1.74079,"marketCap":70939218},{"date":"2025-06-13","current":-170.772047,"twenty":-5.061928,"median":-2.971089,"eighty":-1.74079,"marketCap":72748892},{"date":"2025-06-20","current":-162.275925,"twenty":-5.134435,"median":-2.97107,"eighty":-1.74079,"marketCap":69129544},{"date":"2025-06-27","current":-162.275925,"twenty":-5.170782,"median":-2.97107,"eighty":-1.74079,"marketCap":69129544},{"date":"2025-07-03","current":-184.365843,"twenty":-5.188522,"median":-2.97107,"eighty":-1.74079,"marketCap":78539849},{"date":"2025-07-11","current":-192.861965,"twenty":-5.250613,"median":-2.97107,"eighty":-1.74079,"marketCap":82159197},{"date":"2025-07-18","current":-205.606148,"twenty":-5.308311,"median":-2.97107,"eighty":-1.74079,"marketCap":87588219},{"date":"2025-07-25","current":-211.128627,"twenty":-5.352464,"median":-2.97107,"eighty":-1.74079,"marketCap":89940795},{"date":"2025-08-01","current":-208.154984,"twenty":-5.373499,"median":-2.97107,"eighty":-1.74079,"marketCap":88674023},{"date":"2025-08-08","current":-200.508474,"twenty":-5.396954,"median":-2.97107,"eighty":-1.74079,"marketCap":85416610},{"date":"2025-08-15","current":-3.565624,"twenty":-5.419555,"median":-2.975958,"eighty":-1.74079,"marketCap":91661500},{"date":"2025-08-22","current":-3.42469,"twenty":-5.419555,"median":-2.98346,"eighty":-1.74079,"marketCap":88038516},{"date":"2025-08-29","current":-3.607904,"twenty":-5.419555,"median":-3.010969,"eighty":-1.74079,"marketCap":92748395},{"date":"2025-09-05","current":-4.185733,"twenty":-5.421369,"median":-3.022207,"eighty":-1.74079,"marketCap":107602630},{"date":"2025-09-12","current":-4.171639,"twenty":-5.419555,"median":-3.027742,"eighty":-1.74079,"marketCap":107240332},{"date":"2025-09-19","current":-4.199826,"twenty":-5.419555,"median":-3.029748,"eighty":-1.74079,"marketCap":107964929},{"date":"2025-09-26","current":-4.199826,"twenty":-5.419555,"median":-3.044886,"eighty":-1.74079,"marketCap":107964929},{"date":"2025-10-03","current":-4.325116,"twenty":-5.419555,"median":-3.062786,"eighty":-1.74079,"marketCap":111185762},{"date":"2025-10-10","current":-4.523974,"twenty":-5.419555,"median":-3.072798,"eighty":-1.74079,"marketCap":116297792},{"date":"2025-10-17","current":-4.918588,"twenty":-5.419555,"median":-3.089744,"eighty":-1.74079,"marketCap":126442148},{"date":"2025-10-24","current":-10.006297,"twenty":-5.442949,"median":-3.127325,"eighty":-1.74079,"marketCap":257231878},{"date":"2025-10-31","current":-6.990315,"twenty":-5.484704,"median":-3.13291,"eighty":-1.74079,"marketCap":179700016},{"date":"2025-11-07","current":-8.089598,"twenty":-5.524625,"median":-3.156359,"eighty":-1.74079,"marketCap":207959293},{"date":"2025-11-14","current":-8.991574,"twenty":-5.590448,"median":-3.166034,"eighty":-1.74079,"marketCap":231146391},{"date":"2025-11-21","current":-5.53844,"twenty":-5.6017,"median":-3.203172,"eighty":-1.74079,"marketCap":259758370},{"date":"2025-11-28","current":-5.677869,"twenty":-5.603983,"median":-3.213552,"eighty":-1.74079,"marketCap":266297741},{"date":"2025-12-05","current":-4.601165,"twenty":-5.612604,"median":-3.258879,"eighty":-1.74079,"marketCap":215799261},{"date":"2025-12-12","current":-4.469482,"twenty":-5.612604,"median":-3.313722,"eighty":-1.74079,"marketCap":209623188},{"date":"2025-12-19","current":-4.19175,"twenty":-5.612604,"median":-3.38159,"eighty":-1.74079,"marketCap":196597287},{"date":"2025-12-26","current":-4.975763,"twenty":-5.612604,"median":-3.423963,"eighty":-1.74079,"marketCap":233368261},{"date":"2026-01-02","current":-4.87485,"twenty":-5.612604,"median":-3.466971,"eighty":-1.74079,"marketCap":228635363},{"date":"2026-01-09","current":-6.124613,"twenty":-5.614759,"median":-3.523344,"eighty":-1.74079,"marketCap":287250480},{"date":"2026-01-16","current":-4.952475,"twenty":-5.614759,"median":-3.553584,"eighty":-1.74079,"marketCap":232276053},{"date":"2026-01-23","current":-4.804988,"twenty":-5.614759,"median":-3.572606,"eighty":-1.74079,"marketCap":225358741},{"date":"2026-01-30","current":-5.154301,"twenty":-5.614759,"median":-3.579718,"eighty":-1.74079,"marketCap":241741849},{"date":"2026-02-06","current":-6.272101,"twenty":-5.614759,"median":-3.579718,"eighty":-1.74079,"marketCap":294167792},{"date":"2026-02-13","current":-6.396301,"twenty":-5.614759,"median":-3.579718,"eighty":-1.74079,"marketCap":299992897},{"date":"2026-02-20","current":-6.512738,"twenty":-5.614759,"median":-3.579718,"eighty":-1.74079,"marketCap":305453932},{"date":"2026-02-27","current":-8.406788,"twenty":-5.614759,"median":-3.579718,"eighty":-1.74079,"marketCap":394286781},{"date":"2026-03-06","current":-8.507701,"twenty":-5.616422,"median":-3.579718,"eighty":-1.74079,"marketCap":399019678},{"date":"2026-03-13","current":-8.251538,"twenty":-5.637629,"median":-3.579718,"eighty":-1.74079,"marketCap":387005400},{"date":"2026-03-20","current":-6.435113,"twenty":-5.637629,"median":-3.579718,"eighty":-1.74079,"marketCap":301813242},{"date":"2026-03-26","current":-6.683513,"twenty":-5.637629,"median":-3.579718,"eighty":-1.74079,"marketCap":313463452}],"updateTime":1774660125355},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARMP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622004945","title":"Armata Pharmaceuticals FY2025 net loss more than doubled to $174 million; revenue slips 5.22% to $4.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004945?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:07","pubTimestamp":1774469237,"startTime":"0","endTime":"0","summary":"Armata published a fourth-quarter and full-year earnings release.Grant and award revenue was USD 4.9 million, down 5.22%.Research and development expense was USD 23.7 million, down 31.11%, reflecting lower clinical trial activity and lower personnel-related costs.Net loss was USD 173.8 million, including a non-cash loss of USD 121 million from changes in fair value of the convertible loan.Cash, cash equivalents and restricted cash totaled USD 14.1 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL8Ggm6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INVA","BK4007","ARMP"],"gpt_icon":0},{"id":"2622004430","title":"Armata Pharmaceuticals Inc - Q4 2025 Net Loss $-3.42 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004430?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:05","pubTimestamp":1774469101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUA8XWLM7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2622046780","title":"Press Release: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622046780","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622046780?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:05","pubTimestamp":1774469100,"startTime":"0","endTime":"0","summary":"LOS ANGELES, March 25, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc.  , a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its fourth quarter and full-year ended December 31, 2025.Grant Revenue. The Company recognized grant revenue of $1.1 million for the three months ended December 31, 2025 as compared to $1.2 million in the comparable period in 2024, which represents MTEC's share of the costs incurred for the Company's AP-SA02 program for the treatment of Staphylococcus aureus bacteremia.Net Income . The net loss for the fourth quarter of 2025 was $124.3 million, or $ per share on a basic and diluted basis, as compared to a net income of $2.6 million, or $0.07 per share on a basic and $ per share on a diluted basis, for the comparable period in 2024. The net loss for the quarte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2620443462","title":"Armata Pharmaceuticals delays Q4 and full-year 2025 results announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620443462","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620443462?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:02","pubTimestamp":1773918134,"startTime":"0","endTime":"0","summary":"Armata said it is delaying the announcement of its financial results for the fourth quarter and the year ended Dec. 31, 2025.The company said it needs additional time to complete its financial reporting.Armata expects to file its Annual Report on Form 10-K on or before March 31, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL8ghK4K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARMP","INVA","BK4139"],"gpt_icon":0},{"id":"2620859244","title":"Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2620859244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620859244?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:00","pubTimestamp":1773918001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUA7MYRPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2613807947","title":"Armata price target raised to $15 from $9 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2613807947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613807947?lang=en_us&edition=fundamental","pubTime":"2026-02-23 22:38","pubTimestamp":1771857492,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Armata Pharmaceuticals (ARMP) to $15 from $9 and keeps a Buy rating on the shares after the compa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/armata-price-target-raised-to-15-from-9-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/armata-price-target-raised-to-15-from-9-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2613140780","title":"Armata Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $15 From $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2613140780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613140780?lang=en_us&edition=fundamental","pubTime":"2026-02-23 22:32","pubTimestamp":1771857158,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nAZN4SHU2T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2613781357","title":"FDA Grants QIDP Designation to Armata Pharmaceuticals’ AP-SA02","url":"https://stock-news.laohu8.com/highlight/detail?id=2613781357","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613781357?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:03","pubTimestamp":1771848184,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals said the U.S. Food and Drug Administration granted Qualified Infectious Disease Product  designation to its Staphylococcus aureus multi-phage candidate AP-SA02 for intravenous use as an adjunct treatment for complicated bacteremia caused by methicillin-sensitive or methicillin-resistant S. aureus. The designation provides eligibility for incentives under the GAIN Act, including an additional five years of market exclusivity, and may support potential fast track and priority review pathways.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDLbcTm7P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007","BK4139","ARMP"],"gpt_icon":0},{"id":"2613789084","title":"Armata: Plans to Advance AP-Sa02 Into Phase 3 Superiority Study in Complicated S. Aureus Bacteremia, Anticipated to Initiate in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613789084?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:00","pubTimestamp":1771848003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUABDJWXR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2613789082","title":"Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (Qidp) Designation for AP-Sa02","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613789082?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:00","pubTimestamp":1771848003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUABDJWXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2613202928","title":"U.S. RESEARCH ROUNDUP-Akamai Technologies, Albemarle, Nordson","url":"https://stock-news.laohu8.com/highlight/detail?id=2613202928","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613202928?lang=en_us&edition=fundamental","pubTime":"2026-02-23 15:27","pubTimestamp":1771831633,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Akamai Technologies, Albemarle, NordsonFeb 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akam","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL4N3ZJ0D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBDC","CVNY","ALB","AJG","ACLX","ALBG","LNT","AMD","CAR","BMNZ","BBDC","AMDY","CBRE","BXP","ASAN","AKAM","AMDU","ADBE","BMNR","AIR","AXGN","AMZN","AMDL","CVNX","AD","BLDR","OTF","CAVA","CWST","BBWI","ADC","CE","LEU","ADSK","DAMD","ACAD","ANF","TGT","ARMP","BMY","GOOGL","BKNG","CVNA","ARDX","BMNU","BURL","MO","BSY","BBY","BKNU"],"gpt_icon":1},{"id":"2606424890","title":"Armata Pharmaceuticals Inc - Amends Four Existing Credit Agreements - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2606424890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606424890?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:04","pubTimestamp":1769432646,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0P7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2606248674","title":"Armata Pharmaceuticals Extends Loan Maturities With Innoviva to 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2606248674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606248674?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:01","pubTimestamp":1769432513,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals Inc. has announced amendments to four existing credit agreements with Innoviva Strategic Opportunities LLC, a subsidiary of Innoviva, Inc., a principal shareholder of Armata. The amendments, entered into on January 23, 2026, extend the maturity date of each loan to June 1, 2027. These agreements involve Armata as the borrower, Innoviva Sub as the lender, and certain Armata subsidiaries as guarantors. The amendments apply to credit and security agreements originally dated March 12, 2025, March 4, 2024, July 10, 2023, and January 10, 2023.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gatherin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL66wZVz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ARMP","INVA"],"gpt_icon":0},{"id":"2603668140","title":"Rpt-Armata Pharmaceuticals Inc: FDA Agreed That Data From Phase 2a Disarm Study Support Advancement of AP-Sa02 to a Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2603668140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603668140?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:59","pubTimestamp":1768309165,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL8N3YE0XP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2603686679","title":"Armata Advances Phage Therapy Candidate AP-SA02 to Phase 3 After Positive FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2603686679","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603686679?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:01","pubTimestamp":1768305709,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals Inc. has announced that its Phase 2a diSArm study demonstrated the first evidence of efficacy for phage therapy in a randomized controlled trial, targeting complicated Staphylococcus aureus bacteremia. Following feedback from the U.S. Food and Drug Administration  after an End-of-Phase 2 meeting, the FDA agreed that the safety and efficacy data support advancing Armata's bacteriophage product candidate, AP-SA02, to a Phase 3 clinical trial. Armata intends to initiate this pivotal superiority study later this year, which would be the first superiority-based pivotal trial for an antibacterial drug candidate in several decades. The company is currently addressing FDA recommendations on study design and manufacturing in preparation for the upcoming trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL477yNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4007","BK4139","INVA"],"gpt_icon":0},{"id":"2603863496","title":"Armata Pharmaceuticals Inc: Phase 3 Study Is Anticipated to Initiate in Second Half of 2026.","url":"https://stock-news.laohu8.com/highlight/detail?id=2603863496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603863496?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:00","pubTimestamp":1768305604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE04N:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2603268634","title":"Armata Pharmaceuticals Announces End-of-Phase 2 Meeting With FDA and Plans to Advance AP-Sa02 to a Phase 3 Superiority Study in Complicated Bacteremiastaphylococcusaureus","url":"https://stock-news.laohu8.com/highlight/detail?id=2603268634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603268634?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:00","pubTimestamp":1768305604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE04N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2601835630","title":"Armata Pharmaceuticals Initiated at Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2601835630","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601835630?lang=en_us&edition=fundamental","pubTime":"2026-01-06 00:46","pubTimestamp":1767631560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARMP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 05, 2026 11:46 ET (16:46 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2601886374","title":"Armata Pharmaceuticals Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601886374?lang=en_us&edition=fundamental","pubTime":"2026-01-05 20:07","pubTimestamp":1767614847,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60B0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2584346469","title":"Armata Pharmaceuticals Reports Positive Phase 2a Results for AP-SA02 in Staph Aureus Bacteremia","url":"https://stock-news.laohu8.com/highlight/detail?id=2584346469","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584346469?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:00","pubTimestamp":1763467259,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals Inc., a clinical-stage biotechnology company specializing in bacteriophage therapeutics, announced that it will be featured in a key opinion leader webinar on November 25, 2025, focusing on Staphylococcus aureus  bacteremia and its investigational phage therapy, AP-SA02. The company previously presented positive results from its diSArm study at IDWeek 2025. The diSArm study was a Phase 1b/2a, multicenter, randomized, double-blind, placebo-controlled trial evaluating the safety, tolerability, and efficacy of intravenous AP-SA02 in combination with best available antibiotic therapy  versus BAT alone in adults with complicated S. aureus bacteremia. Results indicated that the combination of AP-SA02 and BAT achieved higher and earlier cure rates compared to BAT alone, with AP-SA02 showing a 100% response rate without relapse at key follow-up points, while the placebo group exhibited an approximate 25% relapse or lack of response. AP-SA02 was reported to be well-tolera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL6CDWYR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4007","BK4139","INVA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}